Myles Hume, Author at Insight - Page 14 of 104

Thursday, April 25, 2024

No Results

View All Results

No Results

View All Results

Home Author

Myles Hume

Maintaining independence and quality of life is vital for people who are blind or visually impaired.

Eye disease

Eyes for Life Canberra launches for blind and low vision community

August 31, 2023

Optometrist opportunities EssilorLuxottica

Feature

Optometrist opportunities beyond the consulting room at EssilorLuxottica ANZ

Glaukos is best known for its glaucoma therapies, launching its first MIGS device commercially in 2012.

Business

Glaukos reaches deal over Radius XR wearable patient engagement and diagnostic technology

IZERVAY geographic atrophy

Business

FDA approves Iveric Bio’s IZERVAY for geographic atrophy

The American Medical Association’s United States Adopted Names (USAN) Council, with the WHO, approved the name.

Business

Opthea chooses non-proprietary drug name ‘sozinibercept’ for OPT-302

Rayner is one company that has adopted the hydrophilic material for its new RayOne EMV platform.

Cataract

Dr Ben LaHood makes the case for hydrophilic IOLs

SMITH ChromaPop lenses are designed to filter light at two specific wavelengths.

Business

SMITH Optics Australia and CR Labs form ChromaPop prescription sun lens partnership

Sexual harassment australia optometry health ophthalmology

Ahpra/National Boards

Ahpra bolsters investigations unit as sexual misconduct complaints rise

Bianca Romeo on a 2022 OneSight trip.

Feature

Why optometrist Bianca Romeo started her career in Alice Springs

When creating customised eyewear, one can choose the colour, texture, and finishing of the acetate. Image: madebyavision

Frames

Creating personalised eyewear – Gladys Mak

Page 14 of 104 Prev 1 … 13 14 15 … 104 Next

Subscribe to our newsletter

About Insight

Popular Topics

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results

View All Results

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited